Facing death, returning to life: A qualitative analysis of MDMA-assisted therapy for anxiety associated with life-threatening illness.

William Barone¹, Michiko Mitsunaga-Whitten², Lia Osunfunláyò Blaustein³, Phillip Perl^4,5, Marisa Swank⁶, Thomas Cody Swift⁷

¹Lucin Psychology Consultation, Oakland, CA, United States.

²Kintsugi Psychotherapy LLC, Boulder, CO, United States.

³The JFK School of Psychology, National University, Pleasant Hill, CA, United States.

⁴MAPS Public Benefit Corporation, San Jose, CA, United States.

⁵University of California, San Francisco, San Francisco, CA, United States.

⁶Department of Psychosocial and Psychoanalytic Studies, University of Essex, Colchester, United Kingdom.

⁷School of Medicine, Johns Hopkins University, Baltimore, MD, United States.

PubMed PMC DOI PDF

Abstract

Anxiety associated with life-threatening illness (LTI) is a pervasive mental health issue with a wide impact. A spectrum of traditional pharmacotherapies and psychotherapies are available, but offer varying success in reducing symptoms and improving quality of life. We explore a novel therapy for this condition by assessing prominent thematic elements from participant narrative accounts of a pilot…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.